NCI Fellowship Recipients

NCI Immunotherapy Fellowship Recipients

The NCI Immunotherapy Fellowship is a training program designed for physicians who have completed a medical oncology fellowship program and who seek specialized training in immunotherapy with clinical trials and clinical trial development. The breadth and depth of opportunities for training in clinical immunotherapy at the Center for Cancer Research (CCR), NCI, are unsurpassed with active clinical programs in therapeutic cancer vaccines, immune checkpoint modulation, adoptive cellular therapies (both TCR engineered cells and CAR-T therapy), bispecific antibodies and immunocytokines. Co-sponsored by the National Cancer Institute (NCI) and SITC and made possible in part by an educational grant from EMD Serono.

Elisabetta Xue, MD
Elisabetta Xue, MD
San Raffaele Hospital
Term: 2023-2024

Alexander Rankin, MD
Alexander Rankin, MD
Children’s Hospital Colorado, University of Colorado
School of Medicine
Term: 2023-2024

Dara Bracken-Clarke, MD
Dara Bracken-Clarke, MD
Waterford University Hospital (Ireland)
Term: 2022-2024

Vincent Poon, MD
Vincent Poon, MD
BC Cancer Vancouver
Term: 2022-2023

Nicholas Tschernia, MD
Nicholas Tschernia, MD
University of North Carolina at
Chapel Hill
Term: 2021-2023

John Shin, MD

John Shin, MD
Mayo Clinic Rochester
Term: 2020-2021


Lekha Mikkilineni, MD

Lekha Mikkilineni, MD
National Cancer Institute,
National Institute of Health,
United States
Term: 2019-2020


Jason Redman, MD

Jason Redman, MD
National Cancer Institute,
National Institute of Health,
United States
Term: 2018-2019


Ariel E. Marciscano, MD
Ariel E. Marciscano, MD
Johns Hopkins University
Term: 2017-2018

Julius Strauss, MD

Julius Strauss, MD
National Cancer Institute,
National Institute of Health,
United States
Term: 2016-2017